Combination therapy for psoriasis with methotrexate and etretinate
- 31 January 1986
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 14 (1), 70-73
- https://doi.org/10.1016/s0190-9622(86)70009-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chronic active hepatitis associated with etretinate therapyBritish Journal of Dermatology, 1985
- Serial liver biopsies in psoriatic patients receiving long-term etretinateBritish Journal of Dermatology, 1985
- Histologic changes in the liver during etretinate treatmentJournal of the American Academy of Dermatology, 1984
- Risk of carcinogenicity in patients with psoriasis treated with methotrexate or PUVA singly or in combinationJournal of the American Academy of Dermatology, 1983
- SYNERGISTIC CARCINOGENIC POTENTIAL OF METHOTREXATE AND PUVA IN PSORIASISThe Lancet, 1983
- Toxic Hepatitis due to Combination Therapy with Methotrexate and Etretinate in PsoriasisDermatology, 1983
- ETRETINATE IN TREATMENT OF ACTINIC KERATOSISThe Lancet, 1982
- Side Effects Due to RO 10-9359 (Tigason)Dermatology, 1982
- A Case of Centrolobular Toxic Necrosis of the Liver Due to Aromatic Retinoid – Tigason (Ro 10-9359)Dermatology, 1980
- Oral Treatment of Psoriasis and Pustulosis Palmo-plantaris with Ro 10-9359Dermatology, 1978